Arterialized oxygen tension and unfavorable clinical outcomes in pediatric cystic fibrosis

儿童囊性纤维化动脉血氧分压与不良临床结局

阅读:1

Abstract

INTRODUCTION: Maintaining good lung function is a primary goal in managing Cystic Fibrosis (CF). As spirometry lacks sensitivity for detecting mild lung disease, early progression often remains unrecognized. To overcome this limitation, more sensitive monitoring tools are needed. We evaluated arterialized oxygen tension (pO(2)) as an easily accessible, and widely applicable surveillance method. METHODS: In this retrospective observational single-center cohort study, arterialized gas exchange was assessed in 103 young people with CF (47 females, 56 males, aged 5-18 years). Trends from baseline (age 5 years) to early adulthood and performance relative to annual best pulmonary function (FEV1) and lung clearance index were examined, along with baseline oxygen tension's predictive value on future FEV1 decline and the occurrence of CF-related complications. RESULTS: pO(2) correlated significantly with FEV1 (p < 0.001) and inversely with lung clearance index (p < 0.001). Higher pO₂ was associated with pancreatic sufficiency (p = 0.069) and dual CFTR modulator use (p < 0.05), with no differences by sex or chronic Pseudomonas aeruginosa infection. By age 5, 19.8% of young individuals with CF had pO₂ below 80 mmHg (5th percentile), of whom 73.7% had normal FEV1. A linear mixed model showed a steeper FEV1 decline in those with abnormal pO(2) at baseline [estimate = 0.06 (Z-score*year(-1)), p < 0.001]. Early low pO(2) was significantly associated with a higher probability of allergic bronchopulmonary aspergillosis (HR = 7.69, p = 0.016) and a trend towards early CF-related diabetes (HR = 2.78, p = 0.06) and early chronic Pseudomonas aeruginosa infection (HR = 2.38, p = 0.09). CONCLUSIONS: Early abnormal pO(2) at age 5 significantly correlated with accelerated FEV1 decline and a greater probability for CF-related complications. Implementing arterialized oxygen tension may offer valuable insights beyond spirometry alone in identifying high-risk patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。